This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Clorox (CLX) Retain Earnings Beat Trend Despite All Odds?
by Zacks Equity Research
Clorox's (CLX) second-quarter fiscal 2019 results are poised to benefit from the ongoing 2020 Strategy, e-commerce enhancement and brand investments. However, margin woes may hurt results.
Can Clorox's Strategic Growth Efforts Offset Margin Issues?
by Zacks Equity Research
Clorox (CLX) witnesses strained margins due to higher costs. Nevertheless, its 2020 Strategy and Go Lean initiative to rebuild margins are encouraging.
UN or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CLX: Which Stock Is the Better Value Option?
Clorox's (CLX) 2020 Strategy on Track, Margin Woes Linger
by Zacks Equity Research
Clorox (CLX) benefits from 2020 strategy, expansion of e-commerce capabilities and brand management initiatives. However, dismal margins and soft fiscal earnings view are concerns.
UL vs. CLX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Why Is Clorox (CLX) Up 8% Since Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Gains 35% in 6 Months: Will the Rally Continue?
by Zacks Equity Research
Clorox (CLX) benefits from its solid strategic efforts, including 2020 strategy, expansion of e-commerce capabilities and brand management initiatives.
Clorox (CLX) Earnings and Sales Surpass Estimates in Q1
by Zacks Equity Research
Clorox (CLX) posts solid first-quarter fiscal 2019 numbers. Further, management trimmed its earnings view for the fiscal year, while reaffirmed sales outlook.
Clorox (CLX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 1.89% and 1.72%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
CLX, EL Q1 Earnings on Oct 31: Here are the Key Predictions
by Zacks Equity Research
Clorox (CLX) and Estee Lauder (EL) are slated to report first-quarter fiscal 2019 results on Oct 31.
Can Clorox (CLX) Retain its Earnings Beat Streak in Q1?
by Zacks Equity Research
Clorox (CLX) gains from its 2020 Strategy, Go Lean Strategy, enhancement of e-commerce business and disciplined capital allocation, which are likely to drive first-quarter fiscal 2019 results.
Clorox (CLX) Q1 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Clorox (CLX) Could Beat Earnings Estimates Again
by Zacks Equity Research
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Perrigo (PRGO) Hires Consumer Products Veteran as New CEO
by Zacks Equity Research
Teaser: Perrigo (PRGO) hires Murray S. Kessler, a consumer goods veteran, as its new president and chief executive officer (CEO), effective immediately.
Clorox's Annual Report Reveals Significant Progress, Stock Up
by Zacks Equity Research
Clorox (CLX) issues its integrated annual report for fiscal 2018, which marks the seventh consecutive year of the release.
Why Clorox (CLX) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Can Clorox's (CLX) Growth Strategies Offset Margin Woes?
by Zacks Equity Research
Clorox's (CLX) solid growth strategies, including 2020 Strategy, bode well. These initiatives are likely to offset margin pressures moving ahead.
UN or CLX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UN vs. CLX: Which Stock Is the Better Value Option?
Clorox (CLX) Surges 24% in 3 Months: More Room to Run?
by Zacks Equity Research
Clorox's (CLX) is moving up the charts thanks to its robust earnings surprise history and progress on the 2020 Strategy.
Clorox's (CLX) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Clorox (CLX) posts better-than-expected earnings in fourth-quarter fiscal 2018 owing to higher revenues, lower tax rate and advertising costs as well as gains from cost savings.
Clorox (CLX) Q4 Earnings Top Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 5.06% and -1.42%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
CHD, CLX Earnings on Aug 2: Here are the Key Predictions
by Zacks Equity Research
Church & Dwight (CHD) and Clorox (CLX) are expected to release earnings on Aug 2.
Will Clorox (CLX) Beat Q4 Earnings Despite Margin Woes?
by Zacks Equity Research
Clorox (CLX) is on track with the 2020 Strategy and efforts to strengthen its e-commerce platform, which is expected to boost sales and profitability.
Why Is Clorox (CLX) Up 8.7% Since Its Last Earnings Report?
by Shremoyee Mandal
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.